Across TCGA pan-cancer cohorts, ATP11AUN Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ATP11AUN data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ATP11AUN Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ATP11AUN expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

COAD, SKCM, and UCEC are the cancer types where ATP11AUN Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.056	0.871	<.001	36	view →
SKCM	DFS	Median	All	0.266	0.739	<.001	18	view →
UCEC	DFS	Median	All	1.000	0.630	.039	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: ATP11AUN tumor-vs-normal RNA expression · all ATP11AUN data types